company

NOVELAKLINIKKEN DRAMMEN AS

3048 DRAMMEN

Return on Equity
587,5 %
Current Ratio
0,95
Debt-to-Equity Ratio
−0
Key figures (NOK)2022
Revenue4 061 000
Net Income−94 000
Total Assets1 040 000
Total Equity−16 000
Income (NOK)2022
Revenue4 061 000
Expenditure4 156 000
Operating Profit−94 000
Financial Income0
Financial Costs0
Financial Balance0
Earnings Before Tax−94 000
Tax0
Net Income−94 000
Balance (NOK)2022
Total Fixed Assets32 000
Total Current Assets1 008 000
Total Assets1 040 000
Total Retained Equity−348 000
Total Equity−16 000
Total Long-Term Debt0
Total Current Debt1 056 000
Total Equity and Debt1 040 000
Cash flow (NOK)2022
Sales Income4 061 000
Other Income0
Revenue4 061 000
Cost of Goods Sold1 368 000
Salary Costs1 866 000
Depreciation30 000
Impairment0
Expenditure4 156 000
Operating Profit−94 000
Financial Income0
Financial Costs0
Financial Balance0
Dividends0
Net Income−94 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures32 000
Total Tangible Assets32 000
Total Fiancial Fixed Assets0
Total Fixed Assets32 000
Stock121 000
Total Investments0
Cash, Bank309 000
Total Current Assets1 008 000
Total Assets1 040 000
Total Equity−16 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors85 000
Unpaid Taxes202 000
Dividends0
Other Current Debt769 000
Total Current Debt1 056 000
Total Equity and Debt1 040 000
Financial indicators2022
Return on Equity587,5 %
Debt-to-Equity Ratio−0
Operating Profit Margin−2,31 %
Current Ratio0,95
Quick Ratio1,08
Equity Ratio−0,02
Gross Profit Margin66,31 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English